Home > Research > Publications & Outputs > Antiviral Nanomedicine‑Based Approaches against...

Electronic data

  • s40506-024-00271-4 (1)

    Final published version, 1.04 MB, PDF document

    Available under license: CC BY: Creative Commons Attribution 4.0 International License

Links

Text available via DOI:

View graph of relations

Antiviral Nanomedicine‑Based Approaches against Epstein‑Barr Virus Infection

Research output: Contribution to Journal/MagazineReview articlepeer-review

Published
Close
<mark>Journal publication date</mark>1/06/2024
<mark>Journal</mark>Current Treatment Options in Infectious Diseases
Issue number2
Volume16
Number of pages14
Pages (from-to)58-71
Publication StatusPublished
Early online date17/02/24
<mark>Original language</mark>English

Abstract

Purpose of Review
The Epstein-Barr virus (EBV) is a common virus around the globe with approximately 98% of adults testing positive against EBV. However, EBV infection typically begins early in the childhood. Owing to the ability to infect various body organ, EBV is linked to a broad spectrum of symptoms, diseases, and inflammatory conditions. Moreover, since EBV exists in both latent and replicating forms in most healthy individuals, any disruption in the balance between the virus and its host can lead to the development of different diseases, including autoimmune disorders and cancer. Given these circumstances, we draw attention to the crucial need for developing prophylactic measures and treatments for EBV and its associated diseases.

Recent Findings
We propose leveraging the advantages of nanomedicine, such as ferritin and iron oxide nanoparticles, for the creation of EBV vaccines. These advancements can also be applied to developing drugs to treat EBV-associated diseases, such as cancer, autoimmune disorders, and cytokine storm syndrome.

Summary
We emphasize the urgency of having accessible EBV vaccines, as well as effective treatments for EBV-related diseases, especially when early diagnosis is involved. This approach, which includes comprehensive cytokine profiling for patients, can significantly enhance the effectiveness of treatment programs.